World Savara Unveils Research on Rare Lung Disease at ERS Congress 2025 Savara Inc. (Nasdaq: SVRA) will present significant research findings on autoimmune pulmonary alveolar proteinosis (aPAP) at the upcoming European Respiratory Society (ERS) Congress 2025.... Editorial10 hours ago